NASDAQ:BCYC

Bicycle Therapeutics Earning Date

USA |NASDAQ |USD |ADR

BCYC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 3, 2021 Sep 2021 $-0.61 $-0.74 $-0.52
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 3, 2021 Sep 2021 $4.43M $1.78M $3.84M

Bicycle Therapeutics's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 2021.

BCYC Earnings Date & History Chart

BCYC Earnings & Revenue Forecast

BCYC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-0.69 $-1.29 $-0.28
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $-2.79 $-3.36 $-2.02
Dec 2022 10 $-3.07 $-4.61 $-0.71

BCYC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 1 $-0.68 $-0.67 $-0.77
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 1 / 3 $-2.75 $-2.77 $-2.68
Dec 2022 1 / 2 $-2.95 $-2.97 $-3.42

BCYC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 10 $4.79M $1.50M $13.40M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 10 $14.13M $6.60M $30.40M
Dec 2022 10 $19.41M $7.14M $67.01M

BCYC Earnings Date & Revenue History

BCYC Earnings History

|
Show More
Show More

BCYC Revenue History

|
Show More
Show More

Bicycle Therapeutics Next Earnings Date & Report

BCYC Next Earnings Date & Report Preview: Sep 2021 (FQ)

BCYC's next earnings date is Wednesday, Nov 3, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 10 analysts, the average EPS estimation for Bicycle Therapeutics's next quarterly earnings is $-0.61, with a low EPS estimation of $-0.79, and a high estimation of $-0.26.

Over the last 1 month, EPS estimates have seen 1 upward revisions and 0 downward. The EPS 1 month trend is $-0.59, the last 2 month trend is $-0.59, and the 3 month trend is $-0.47.

Based on 8 analysts, the average revenue estimation is $4.43M, with a low revenue estimation of $1.50M, and a high estimation of $13.40M.

Bicycle Therapeutics Previous Earnings Dates & Reports

BCYC Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bicycle Therapeutics's previous earnings date was Aug 5, 2021 for its fiscal quarter ended Jun 30, 2021.

BCYC's earnings per share (EPS) was $-0.74, missing the consensus analysts forecast of $-0.67 by -10.78%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 1.37%, and lower than the same period a year before (Jun 2020) by 10.45%.

Revenues were $1.78M, worse than the forecast of $2.31M by -22.73%, down by -1.27% from the previous quarter , and up by 13.62% from the same period last year.

The company reported a net income of $-17.91M.

Free cash flow for the quarter was $-26.87M , compared to $-14.33M last quarter and $-12.65M a year before.

BCYC ended the quarter with $30.40M in total debt, a decrease of -8.52% compared to the previous quarter, and an increase of 1922.69% compared to the same quarter a year before.

BCYC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bicycle Therapeutics's previous annual earnings date was Mar 11, 2021 for its fiscal year ended Dec 31, 2020.

BCYC's earnings per share (EPS) was $-2.65, missing the consensus analysts forecast of $-2.27 by 16.74% , and lower than the previous year's EPS (Dec 2019) by 36.99%.

Revenues were $10.39M, worse than the forecast of $10.62M by -2.17%, and down by -24.72% from previous year's revenue.

The company reported a net income of $-51.01M.

Bicycle Therapeutics reported a free cash flow of $-18.99M for its fiscal year, compared to $-30.17M a year ago.

The company ended the fiscal year with $15.35M in total debt, an increase of 711.69% compared to the previous year.